Nanomix Corporation
$0.00$0.00 (0.0%)
Nanomix Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
OTC · EQUR · USD
Stock price, earnings
Quote as of Aug 14, 2023, 05:52 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow E-Qure Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
E-Qure Corp., a medical technology firm, is dedicated to the development and distribution of medical devices that utilize bioelectrical signal therapy (BST). These BST devices leverage their exclusive and patented electrical stimulation techniques to address and resolve challenging, difficult-to-heal wounds and ulcers, aiming for their full closure and recovery. The company was founded in 1988 and operates from its headquarters in New York, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Nanomix Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
NeonMind Biosciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
$0.00-$0.00 (0.0%)
MobileSmith, Inc.: Healthcare · Medical - Healthcare Information Services.
$0.00$0.00 (0.0%)
EastWest Bioscience Inc.: Healthcare · Medical - Pharmaceuticals.
$0.00$0.00 (0.0%)
Gelesis Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
$0.00+$0.00 (+9,900.0%)
Gene Biotherapeutics, Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
Capha Pharmaceuticals Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Acacia Diversified Holdings, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.